How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

52,400 results for

Topical Paste

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Relationship of Skin Related SNP to Topical Skin Care Product

to unacceptable risks. (i.e. oral or topical steroids or anti-inflammatories, etc.). Uncontrolled metabolic disease such as diabetes, hyperthyroidism, or hypothyroidism or active Hepatitis, immune deficiency, or autoimmune disease as determined by the health questionnaire. Pregnancy, nursing, or planning to become pregnant during the course of the study as determined by the health questionnaire. History of skin cancer within the past 6 months. Use of topical prescription retinoids for anti-aging including (...) Relationship of Skin Related SNP to Topical Skin Care Product Relationship of Skin Related SNP to Topical Skin Care Product - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Relationship of Skin Related SNP

2018 Clinical Trials

102. Topical Treatment for Sexual Pain, Vulvar Pain, in Postmenopausal Women Not Taking Estrogens or Similiar Hormones

Topical Treatment for Sexual Pain, Vulvar Pain, in Postmenopausal Women Not Taking Estrogens or Similiar Hormones Topical Treatment for Sexual Pain, Vulvar Pain, in Postmenopausal Women Not Taking Estrogens or Similiar Hormones. Women on Tamoxifen CAN Enter the Clinical Trial - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study (...) Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Topical Treatment for Sexual Pain, Vulvar Pain, in Postmenopausal Women Not Taking Estrogens or Similiar Hormones. Women on Tamoxifen CAN Enter the Clinical Trial The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies

2018 Clinical Trials

103. Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search (...) for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has

2018 Clinical Trials

104. To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).

the evaluation of the psoriasis vulgaris (e.g., atopic dermatitis, contact dermatitis, tinea corporis). Presence of pigmentation, extensive scarring, pigmented lesions, or sunburn in the treatment areas that could interfere with the rating of efficacy parameters. History of psoriasis unresponsive to topical treatments. History of hypersensitivity to any component of the Test or Reference product. Current or past history of hypercalcemia, calcium metabolism disorder, vitamin D toxicity, severe renal (...) To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis). To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis). - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved

2018 Clinical Trials

105. Allergic Contact Dermatitis To Personal Care Products And Topical Medications In Adults With Atopic Dermatitis. (PubMed)

Allergic Contact Dermatitis To Personal Care Products And Topical Medications In Adults With Atopic Dermatitis. Atopic dermatitis (AD) is associated with skin-barrier disruption, immune dysregulation, and application of emollients and topical medications that might predispose a person toward developing allergic contact dermatitis.To determine the predictors of allergic contact dermatitis and relevant allergens in AD.A retrospective chart review was performed for 502 adults (age ≥18 years) who (...) were patch tested to an expanded allergen series during 2014-2017.Overall, 108 (21.5%) had current AD and 109 (21.7%) had past AD. Patients with and without current AD had similar proportions of any positive (+, ++, or +++ 80 [74.1%] vs 254 [64.5%], respectively, chi-squared P = .06); strong-positive (++ and +++ 34 [31.5%] vs 102 [25.9%], respectively, P = .25); and irritant (56 [51.9%] vs 188 [47.7%], respectively, P = .45) patch-test reactions. AD patients had significantly higher rates

2018 Journal of American Academy of Dermatology

106. Steroid phobia among general users of topical steroids: a cross-sectional nationwide survey. (PubMed)

Steroid phobia among general users of topical steroids: a cross-sectional nationwide survey. The aim of this study was to assess steroid phobia among general users of topical corticosteroids and to analyze factors associated with steroid phobia.A cross-sectional nationwide survey was conducted using an online panel with participants stratified by age, sex, and region. Those aged 18-65 years with experience of topical steroid use within the past 1 year were included.Of the 3000 respondents (...) included, 929 (31%) had steroid phobia. Among those with steroid phobia, 322 (35%) reported that their fear developed after obtaining information from the media. Weight gain, asthma, skin thinning, growth stunting, and skin aging were the side effects cited as the main reasons behind development of steroid phobia. Female respondents and those with experience of the side effects of topical steroids were more likely to have steroid phobia, while those who obtained information on topical steroid use from

2018 Journal of Dermatological Treatment

107. Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure

with significant medical history or current skin diseases that the investigator feels is not safe for study participation; Subjects who have been treated with systemic retinoids or steroids within the past month prior to entry to the study; Subjects who have been treated with topical steroids, retinoids or other topical drugs used within 2 weeks prior to entry to the study; Recently treated or current skin diseases that would affect clinical evaluation and biopsy; Subjects with a known allergy to broccoli (...) Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2018 Clinical Trials

108. A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis

months, and/or a history of 2 or more episodes of eczema herpeticum in the past. Participants who are currently experiencing a skin infection that requires treatment, or is currently being treated, with topical or systemic antibiotics. Have any serious illness that is anticipated to require the use of systemic corticosteroids or otherwise interfere with study participation or require active frequent monitoring (e.g., unstable chronic asthma). Have been treated with the following therapies: Monoclonal (...) A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have

2018 Clinical Trials

109. Cardiac Shock Care Centers: JACC Review Topic of the Week. (PubMed)

Cardiac Shock Care Centers: JACC Review Topic of the Week. Despite advances over the past decade, the incidence of cardiogenic shock secondary to acute myocardial infarction has increased, with an unchanged mortality near 50%. Recent trials have not clarified the best strategies in treatment. While dedicated cardiac shock centers are being established, there are no standardized agreements on the utilization of mechanical circulatory support and the timeliness of percutaneous coronary

2018 Journal of the American College of Cardiology

110. Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy

Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record (...) Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy (JADE Compare) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S

2018 Clinical Trials

111. Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A

Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration (...) or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A (ECZTRA 7) The safety and scientific validity of this study is the responsibility of the study sponsor

2018 Clinical Trials

112. Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease

Intervention/treatment Phase Autoimmune Behcet Syndrome Radiation: Diode laser 980nm&100 mWatt Drug: Triamcinolone Acetonide Not Applicable Detailed Description: The enrolled patients will be divided randomly into two groups.one group will receive Diode Laser (power:100 milli Watt,wavelength:980 mmm, delivery system:biostimulation probe) and other group will receive topical corticosteroids(Kenacort A Orabase: triamcinolone acetonide 0.1% 5 gram adhesive paste - Dermaphor) four times daily. Study Design Go (...) : Active Control,Randomized,Double- Blinded Clinical Trial of BD Estimated Study Start Date : February 25, 2019 Estimated Primary Completion Date : February 25, 2019 Estimated Study Completion Date : February 25, 2019 Resource links provided by the National Library of Medicine related topics: related topics: available for: resources: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Triamcinolone acetonide Triamcinolone acetonide 0.1% 5 gm adhesive paste 4 times / day for 1

2018 Clinical Trials

113. Disinfection by triple antibiotic paste during regenerative endodontic treatment

Disinfection by triple antibiotic paste during regenerative endodontic treatment UTCAT827, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Disinfection By Triple Antibiotic Paste During Regenerative Endodontic Treatment Clinical Question In treating a patient with an immature permanent tooth with pulpal necrosis, will a regenerative endodontic treatment with disinfection by a triple antibiotic paste compared (...) with calcium hydroxide paste, or formocresol paste produce better results in root development? Clinical Bottom Line Treating the root canal with a triple antibiotic paste produces better results in root development than calcium hydroxide or formocresol treatment. (See Comments on the CAT below) Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Bose/2009 48 cases of regenerative endo and a control of 40 Case

2011 UTHSCSA Dental School CAT Library

114. Topics in Complementary and Alternative Therapies (PDQ®): Patient Version

Topics in Complementary and Alternative Therapies (PDQ®): Patient Version Topics in Integrative, Alternative, and Complementary Therapies (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf Warning: The NCBI web site requires JavaScript to function. Search database Search term Search NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. PDQ Cancer (...) Information Summaries [Internet]. Bethesda (MD): ; 2002-. Search term Topics in Integrative, Alternative, and Complementary Therapies (PDQ®) Patient Version PDQ Integrative, Alternative, and Complementary Therapies Editorial Board . Published online: November 2, 2018. Created: March 29, 2013 . This PDQ cancer information summary has current information about the complementary and alternative therapies found in other PDQ summaries and NCI Fact Sheets. It is meant to inform and help patients, families

2016 PDQ - NCI's Comprehensive Cancer Database

115. Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future (PubMed)

Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future 27547134 2017 08 23 2018 11 13 1526-6702 43 4 2016 Aug Texas Heart Institute journal Tex Heart Inst J Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future. 287-90 10.14503/THIJ-16-5785 Wehbe Ramsey M RM Yadlapati Ajay A eng Historical Article Journal Article Review 2016 08 01 United States Tex Heart Inst J 8214622 0730-2347 0 Anticoagulants IM Administration (...) , Oral Anticoagulants administration & dosage adverse effects Atrial Fibrillation blood diagnosis drug therapy epidemiology Blood Coagulation drug effects Diffusion of Innovation Guidelines as Topic Hemorrhage chemically induced History, 20th Century History, 21st Century Humans Patient Selection Practice Guidelines as Topic Practice Patterns, Physicians' history trends Risk Assessment Risk Factors Stroke blood diagnosis epidemiology prevention & control Treatment Outcome Administration, oral anti

Full Text available with Trip Pro

2016 Texas Heart Institute Journal

116. EHP Highlights of the Past Year (PubMed)

EHP Highlights of the Past Year 27479990 2018 03 09 2018 03 09 1552-9924 124 8 2016 08 01 Environmental health perspectives Environ. Health Perspect. EHP Highlights of the Past Year. A132 10.1289/EHP777 Darney Sally Perreault SP Environmental Health Perspectives, National Institute of Environmental Health Sciences, National Institutes of Health, U.S. Department of Health and Human Services, Research Triangle Park, North Carolina, USA. eng Editorial United States Environ Health Perspect 0330411 (...) 0091-6765 IM Environmental Health Peer Review, Research Periodicals as Topic Publishing 2016 8 2 6 0 2016 8 2 6 0 2018 3 10 6 0 ppublish 27479990 10.1289/EHP777 PMC4977034

Full Text available with Trip Pro

2016 Environmental health perspectives

117. Using Text Analytics of AJPE Article Titles to Reveal Trends In Pharmacy Education Over the Past Two Decades (PubMed)

Using Text Analytics of AJPE Article Titles to Reveal Trends In Pharmacy Education Over the Past Two Decades Objective. To identify trends in pharmacy education during last two decades using text mining. Methods. Articles published in the American Journal of Pharmaceutical Education (AJPE) in the past two decades were compiled in a database. Custom text analytics software was written using Visual Basic programming language in the Visual Basic for Applications (VBA) editor of Excel 2007 (...) . Frequency of words appearing in article titles was calculated using the custom VBA software. Data were analyzed to identify the emerging trends in pharmacy education. Results. Three educational trends emerged: active learning, interprofessional, and cultural competency. Conclusion. The text analytics program successfully identified trends in article topics and may be a useful compass to predict the future course of pharmacy education.

Full Text available with Trip Pro

2016 American journal of pharmaceutical education

118. Retrospective Study of Acanthamoebic Keratitis During the Past 10 Years

Retrospective Study of Acanthamoebic Keratitis During the Past 10 Years Retrospective Study of Acanthamoebic Keratitis During the Past 10 Years - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Retrospective (...) Study of Acanthamoebic Keratitis During the Past 10 Years The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02763605 Recruitment Status : Unknown Verified May 2016 by National Taiwan University Hospital. Recruitment status was: Recruiting First Posted : May 5, 2016 Last Update Posted : May 9, 2016

2016 Clinical Trials

119. Complications From the Use of Calcium Phosphate Paste in Mandibular Lengthening Osteotomies

Perspective: Prospective Official Title: Prospective Study: Complications From the Use of Calcium Phosphate Paste in Mandibular Lengthening Osteotomies Actual Study Start Date : March 1, 2017 Estimated Primary Completion Date : October 2018 Estimated Study Completion Date : December 2018 Resource links provided by the National Library of Medicine related topics: available for: Groups and Cohorts Go to Group/Cohort Intervention/treatment Standard sagittal split osteotomy group Patients undergoing sagittal (...) Complications From the Use of Calcium Phosphate Paste in Mandibular Lengthening Osteotomies Complications From the Use of Calcium Phosphate Paste in Mandibular Lengthening Osteotomies - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2016 Clinical Trials

120. Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants

Oxide Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants Study Start Date : March 2015 Estimated Primary Completion Date : March 2017 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Calmoseptine Ointment Calmoseptine Ointment as part of a structured skin care regimen. Drug: Calmoseptine Ointment A full structured skin care regimen is provided in a consistent fashion (...) Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants Trial Comparing Calmoseptine Ointment and Desitin Diaper Rash Paste in Diaper Dermatitis in Neonates and Infants - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved

2016 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>